2013, Lance was criticized by the father of a Virginia Tech shooting victim who wanted Lance to be more supportive of gun control measures. In 2016, Lance disagreed with members of Congress who staged a sit-in to force a vote on gun control. In March 2017, Lance was one of two House Republicans who broke with their party to oppose National Rifle Association-supported legislation that would block the Department of Veterans Affairs from reporting veterans considered mentally incompetent to the gun background-check database. In December 2017, Lance opposed the Concealed Carry Reciprocity Act, which would require states to honor concealed weapons permits for people who got them in other states. Lance was one of 24 co-sponsors on legislation that would ban bump stocks. In February 2018, Lance, along with 18 other Republican members of the U.S. House, urged House Speaker Paul Ryan to schedule a vote on legislation, introduced by U.S. Senators John Cornyn (R) and Chris Murphy (D), that would improve the national background check system for gun purchases, a measure to prevent gun violence. That same month, he called for a lifting of the 1996 federal ban of research into gun violence by the Centers for Disease Control and Prevention and co-sponsored legislation which would lift the ban. Health care Lance has been a critic of the Patient Protection and Affordable Care Act (Obamacare) since its inception, voting against it in 2009 and voting to repeal it on multiple occasions. Lance voted to send the American Health Care Act of 2017, the Republican Party's replacement plan for Obamacare, out of committee. He ultimately opposed the legislation on the House floor, becoming the first House Republican in New Jersey to oppose the legislation, and one of 20 who voted against the final bill. Lance is the Republican chairman of the Rare Disease Caucus, a group whose goal is to get Members of Congress to support passing bills that help people who have rare diseases. In 2013, Lance re-introduced the Modernizing Our Drug and Diagnostic Evaluation and Regulatory Network Cures (MODDERN) Act, a bipartisan bill intended to encourage new innovative treatments for a variety of diseases and ailments. The MODDERN Drug Act proposes to reevaluate and reintroduce drugs that were once in the development phase, back into production and testing. This bill would benefit patients with a variety of ailments including but not limited to: degenerative conditions, cancer, and autoimmune